3,5-Difluoro-2-(trifluoromethyl)pyridine, 97.0%, 25g

(1,3-benzoxazol-2-ylmethyl)amine hydrochloride, 95.0%, 100mg

2-Methylsulfonyl-4,6-dimethoxypyrimidine, 97.0%, 1kg

4-Bromo-1,1,3,3,5,5,7,7-octaethyl-1,2,3,5,6,7-hexahydro-s-indacene>95.0%(GC)1g

2-BROMO-IMIDAZO[1,2-A]PYRIDINE-7-CARBOXYLIC ACID METHYL ESTER, 95.0%, 5g

1-(2,2-difluoroethyl)-4-nitro-1H-pyrazole, 1g

Methyl Dichloromethoxyacetate>95.0%(GC)5g

GC capillary column ROTI®Cap-1, 25 m, 0.20 mm, 0.10 µm, 1 Piece(s)

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)decanoic acid, 97%, 1g

2,4-Dichloro-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine 6,6-dioxide, 95.0%, 5g

3-Bromobenzenesulfonamide, 97.0%, 1g

2-((Benzyloxy)methyl)cyclopropanecarboxylic acid, 95.0%, 5g

2,4,6-triphenoxy-1,3,5-triazine, 95.0%, 1g